Lung cancer trends and challenges in Europe and Chile

In early August 2026, health officials reported that lung‑cancer mortality was climbing in Chile and Spain. Chile sees over 4,300 new cases annually and about 3,600 deaths, with early detection identified as the biggest hurdle. Spain’s provisional 2025 data showed a slight rise in deaths, making lung cancer the leading cause of cancer mortality, and highlighted a concerning increase in female deaths.

Later the same day, attention turned to Europe, where the Iberian region and France documented rising lung‑cancer incidence, especially among never‑smokers. Stigma surrounding the disease was noted to delay diagnosis and worsen outcomes. In Spain, the share of non‑smoker cases grew from 7.2 % in 2000 to 12.6 % in 2020, predominantly affecting women, while French experts linked hormonal factors and specific genetic alterations (EGFR, ALK, ROS1) to these tumours. Air‑pollution particles (PM2.5) were also cited as contributing to the increase.

Together, the snapshots illustrate a broader pattern of rising lung‑cancer burden across continents, with emerging risk factors such as non‑smoking exposure, gender disparities, genetic mutations, and environmental pollution, alongside persistent challenges in early detection and social stigma.